Cardiovascular manifestations of HIV infection

被引：132

作者：

Barbaro, G ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Rome, Italy

来源：

CIRCULATION | 2002年 / 106卷 / 11期

关键词：

D O I：

10.1161/01.CIR.0000031704.78200.59

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1420 / 1425

页数：6

共 35 条

[31] Takayasu's arteritis in a human immunodeficiency virus-infected adolescent [J].

Shingadia, D ;

Das, L ;

Klein-Gitelman, M ;

Chadwick, E .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :458-459

[32] Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction [J].

Stein, JH ;

Klein, MA ;

Bellehumeur, JL ;

McBride, PE ;

Wiebe, DA ;

Otvos, JD ;

Sosman, JM .

CIRCULATION, 2001, 104 (03) :257-262

[33] Overview of HIV infection [J].

Temesgen, Z .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (01) :1-5

[34] Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile [J].

van der Valk, M ;

Kastelein, JJP ;

Murphy, RL ;

van Leth, F ;

Katlama, C ;

Horban, A ;

Glesby, M ;

Behrens, G ;

Clotet, B ;

Stellato, RK ;

Molhuizen, HOF ;

Reiss, P .

AIDS, 2001, 15 (18) :2407-2414

[35]

Witz M, 2000, AM J HEMATOL, V64, P137

← 1 2 3 4 →